Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2020 3
2021 8
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial.
Schmidt M, Hajage D, Lebreton G, Dres M, Guervilly C, Richard JC, Sonneville R, Winiszewski H, Muller G, Beduneau G, Mercier E, Roze H, Lesouhaitier M, Terzi N, Thille AW, Laurent I, Kimmoun A, Combes A; PRONECMO Investigators, the REVA Network, and the International ECMO Network (ECMONet). Schmidt M, et al. JAMA. 2023 Dec 26;330(24):2343-2353. doi: 10.1001/jama.2023.24491. JAMA. 2023. PMID: 38038395
[Pulmonary veno-occlusive disease].
Boucly A, Girerd B, Bourlier D, Nemlaghi S, Caliez J, Savale L, Jaïs X, Dorfmüller P, Simonneau G, Sitbon O, Humbert M, Montani D. Boucly A, et al. Among authors: nemlaghi s. Rev Mal Respir. 2018 Feb;35(2):160-170. doi: 10.1016/j.rmr.2017.11.005. Epub 2018 Mar 1. Rev Mal Respir. 2018. PMID: 29501213 Review. French.
Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
Labbé V, Contou D, Heming N, Megarbane B, Razazi K, Boissier F, Ait-Oufella H, Turpin M, Carreira S, Robert A, Monchi M, Souweine B, Preau S, Doyen D, Vivier E, Zucman N, Dres M, Fejjal M, Noel-Savina E, Bachir M, Jaffal K, Timsit JF, Picos SA, Mariotte E, Martis N, Juguet W, Melica G, Rondeau P, Audureau E, Mekontso Dessap A; ANTICOVID Investigators. Labbé V, et al. JAMA Intern Med. 2023 Jun 1;183(6):520-531. doi: 10.1001/jamainternmed.2023.0456. JAMA Intern Med. 2023. PMID: 36946232 Free PMC article.
Severe COVID-19-related encephalitis can respond to immunotherapy.
Cao A, Rohaut B, Le Guennec L, Saheb S, Marois C, Altmayer V, Carpentier VT, Nemlaghi S, Soulie M, Morlon Q, Berthet-Delteil B, Bleibtreu A, Raux M, Weiss N, Demeret S; CoCo-Neurosciences study group. Cao A, et al. Among authors: nemlaghi s. Brain. 2020 Dec 1;143(12):e102. doi: 10.1093/brain/awaa337. Brain. 2020. PMID: 33064794 Free PMC article. No abstract available.
ICU strain and outcome in COVID-19 patients-A multicenter retrospective observational study.
Demoule A, Fartoukh M, Louis G, Azoulay E, Nemlaghi S, Jullien E, Desnos C, Clerc S, Yvin E, Mellati N, Charron C, Voiriot G, Picard Y, Vieillard-Baron A, Darmon M. Demoule A, et al. Among authors: nemlaghi s. PLoS One. 2022 Jul 19;17(7):e0271358. doi: 10.1371/journal.pone.0271358. eCollection 2022. PLoS One. 2022. PMID: 35853020 Free PMC article.
Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies.
Jary A, Marot S, Faycal A, Leon S, Sayon S, Zafilaza K, Ghidaoui E, Quoc SN, Nemlaghi S, Choquet S, Dres M, Pourcher V, Calvez V, Junot H, Marcelin AG, Soulié C. Jary A, et al. Among authors: nemlaghi s. Viruses. 2022 Jan 24;14(2):226. doi: 10.3390/v14020226. Viruses. 2022. PMID: 35215820 Free PMC article.
18 results